ArticleThe Journal of clinical investigation2025
Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanoma.
Manoela Tiago et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it